Literature DB >> 10988015

Mortality from all causes and from coronary heart disease related to smoking and changes in smoking during a 35-year follow-up of middle-aged Finnish men.

Q Qiao1, M Tervahauta, A Nissinen, J Tuomilehto.   

Abstract

AIMS: The risk of early and late death in relation to smoking and ex-smoking were studied. METHODS AND
RESULTS: A cohort of 1711 Finnish men born between 1900 and 1919 were recruited in 1959 and followed up for 35 years. Information on smoking status was collected at each of six examinations made from 1959 to 1989 using a standardized questionnaire. Vital status at the end of 1994 was collected for every man. The effect of smoking on mortality was assessed using Cox proportional hazards model. Adjusted ratios for 35-year all-cause mortality were 1.62 (95% CI 1.40-1.88) in current smokers and 1.13 (CI 0.93-1.36) in former smokers compared with non-smokers. The hazards ratios for 35-year coronary heart disease mortality were 1. 63 (CI 1.24-2.13) and 1.39 (CI 1.00-1.94), respectively. The risk for 10 year mortality was stronger than for 35 year mortality among both former and current smokers, given the same amount of cigarettes consumed. Men smoking persistently were most at risk, while those who persisted in quitting had no increased risk of death compared with non-smokers.
CONCLUSION: Smoking increases the risk of premature death in middle-aged men and giving up smoking earlier in life can prevent smoking attributable premature death. Copyright 2000 The European Society of Cardiology.

Entities:  

Mesh:

Year:  2000        PMID: 10988015     DOI: 10.1053/euhj.2000.2151

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  24 in total

Review 1.  The 2015 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update.

Authors:  Sherilyn K D Houle; Raj Padwal; Luc Poirier; Ross T Tsuyuki
Journal:  Can Pharm J (Ott)       Date:  2015-07

2.  Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment.

Authors:  D F Heitjan; D A Asch; Riju Ray; Margaret Rukstalis; Freda Patterson; C Lerman
Journal:  Pharmacogenomics J       Date:  2008-03-18       Impact factor: 3.550

3.  Smoking and red blood cell phospholipid membrane fatty acids.

Authors:  H J Murff; H A Tindle; M J Shrubsole; Q Cai; W Smalley; G L Milne; L L Swift; R M Ness; W Zheng
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2016-08-16       Impact factor: 4.006

4.  Relationship between amount of cigarette smoking and coronary atherosclerosis on coronary CTA in asymptomatic individuals.

Authors:  Jeong A Kim; Eun Ju Chun; Min Su Lee; Kil Joong Kim; Sang Il Choi
Journal:  Int J Cardiovasc Imaging       Date:  2013-04-27       Impact factor: 2.357

5.  Mortality and life expectancy in relation to long-term cigarette, cigar and pipe smoking: the Zutphen Study.

Authors:  Martinette T Streppel; Hendriek C Boshuizen; Marga C Ocké; Frans J Kok; Daan Kromhout
Journal:  Tob Control       Date:  2007-04       Impact factor: 7.552

6.  Associations Between the Serum Metabolome and All-Cause Mortality Among African Americans in the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Bing Yu; Gerardo Heiss; Danny Alexander; Morgan E Grams; Eric Boerwinkle
Journal:  Am J Epidemiol       Date:  2016-03-07       Impact factor: 4.897

7.  Forty-year mortality from cardiovascular diseases and all causes of death in the US Railroad cohort of the Seven Countries Study.

Authors:  Alessandro Menotti; Daan Kromhout; Henry Blackburn; David Jacobs; Mariapaola Lanti
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

8.  Cigarette smoking induces atrial fibrosis in humans via nicotine.

Authors:  Andreas Goette; Uwe Lendeckel; Anja Kuchenbecker; Alicja Bukowska; Brigitte Peters; Helmut U Klein; Christof Huth; Christoph Röcken
Journal:  Heart       Date:  2007-03-29       Impact factor: 5.994

9.  Interaction of body mass index and diabetes as modifiers of cardiovascular mortality in a cohort study.

Authors:  Seung Hyun Ma; Bo-Young Park; Jae Jeong Yang; En-Joo Jung; Yohwan Yeo; Yungi Whang; Soung-Hoon Chang; Hai-Rim Shin; Daehee Kang; Keun-Young Yoo; Sue Kyung Park
Journal:  J Prev Med Public Health       Date:  2012-11-29

10.  Understanding the effect of smoking and drinking behavior on Parkinson's disease risk: a Mendelian randomization study.

Authors:  Carmen Domínguez-Baleón; Jue-Sheng Ong; Clemens R Scherzer; Miguel E Rentería; Xianjun Dong
Journal:  Sci Rep       Date:  2021-07-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.